Amundi
SVRA icon

Amundi’s Savara SVRA Stock Holding History

Amundi’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-329
Closed -$954 – 2122
2025
Q1 		$954 Buy
329
+27
+9% +$75 ﹤0.01% 2042
2024
Q4 		$918 Buy
+302
New +$1.05K ﹤0.01% 2031

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Amundi's SVRA Position: Q2 2025 in Review

Amundi sold out of Savara (SVRA) in Q2 2025, closing a stake of 329 shares — an estimated $954 sold.

Amundi first reported a position in SVRA in Q4 2024 and held it in 2 quarters. The position peaked at $954 in Q1 2025. 122 funds tracked by Wall St. Rank hold SVRA as of Q2 2025.

  • Amundi reported no remaining Savara position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 329 Savara shares in Q2 2025, an estimated $954.
  • Amundi first reported a position in Savara in Q4 2024 and held it in 2 quarters.
  • Amundi's Savara position peaked at $954 in Q1 2025.
  • 122 funds tracked by Wall St. Rank held Savara as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.